Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
3
33%
Ph phase_3
2
22%
Ph phase_2
1
11%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(8)

Detailed Status

Completed8
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

completed889%
enrolling_by_invitation111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

INDV-6001 Multiple-Dose Pharmacokinetic Study

NCT06576843
enrolling_by_invitationphase_4

Houston Emergency Opioid Engagement System

NCT03396276
completednot_applicable

Providing Suboxone and PrEP Using Telemedicine

NCT04521920
completednot_applicable

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

NCT05108935
completedphase_3

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

NCT02696096
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06576843Phase 2

INDV-6001 Multiple-Dose Pharmacokinetic Study

Completed
NCT03396276Phase 4

Houston Emergency Opioid Engagement System

Enrolling By Invitation
NCT04521920Not Applicable

Providing Suboxone and PrEP Using Telemedicine

Completed
NCT05108935Not Applicable

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Completed
NCT02696096Phase 3

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Completed
NCT00929253Not Applicable

Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)

Completed
NCT02357901Phase 3

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Completed
NCT00733720Phase 1

Buprenorphine Naltrexone-P1 A-Cocaine

Completed
NCT03002961Phase 1

Single Ascending Dose Study of RBP-6000

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9